Epidemiological Profile and Classification of Autoimmune Diseases
in an Internal Medicine Service in Lomé (Togo)

Komi Dzidzonu Nemi; Lihanimpo Djalogue; Abou Bakari Tchala; Toyi Tchamdja; Kossi Kodjo; Abdou Razak Moukaila; Komi Edem Mossi; Kodjo Agbéko Djagadou; Abago Balaka; Mohaman Awalou Djibril

Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research Article Volume 4 Issue 5

Epidemiological Profile and Classification of Autoimmune Diseases in an Internal Medicine Service in Lomé (Togo)

Komi Dzidzonu Nemi¹*, Lihanimpo Djalogue², Abou Bakari Tchala¹, Toyi Tchamdja², Kossi Kodjo¹, Abdou Razak Moukaila¹, Komi Edem Mossi¹, Kodjo Agbéko Djagadou¹, Abago Balaka¹ and Mohaman Awalou Djibril¹

¹Department of Internal Medicine, Sylvanus Olympio Teaching Hospital of Lomé, University of Lomé, Togo
²Department of Internal Medicine, Kara Teaching Hospital, University of Kara, Togo

*Corresponding Author: Komi Dzidzonu Nemi, Internal Medicine, Sylvanus Olympio Teaching Hospital of Lomé, University of Lomé, Lomé, Togo.

Received: April 03, 2020; Published: April 24, 2020

Reprints View PDF Related Articles

Abstract

The purpose of this study was to describe the epidemiology and classification of autoimmune diseases in the department of Internal Medicine of Sylvanus Olympio teaching hospital of Lomé. This is a retrospective study conducted from 1st January 2018 to December 31st 2019 in this department. During the study period, 959 patients were received in the department. Among them, 72 had autoimmune diseases, i.e. a prevalence of 7.5%. The average age of the patients was 31.51 years (range: 17 and 74) and the sex ratio (M/F) was 0.46. The 20 to 39 age group was the most represented (69.44%). Organ-specific autoimmune diseases were type 1 diabetes mellitus (N = 48; 66.7%), Graves' disease (N = 13; 18.05%), autoimmune hemolytic anemia (N = 4; 5.6%) and autoimmune atrophic thyroiditis (N = 2; 2.77%). Graves' disease was associated with type 1 diabetes in one patient. Systemic autoimmune diseases were Rheumatoid arthritis (N = 4; 5.6%), systemic lupus erythematosus (N = 3; 4.2%) and MCTD (N = 1; 1.38%). Rheumatoid arthritis was associated with diabetes in one patient. MCTD was associated with atrophic thyroiditis in also one patient. This study shows that the autoimmune diseases in the Internal Medicine department of Sylvanus Olympio teaching hospital of Lomé are dominated by endocrinopathies namely type1 diabetes and Graves' disease.

Keywords:Autoimmune Diseases; Type 1 Diabetes; Grave's Disease; Lomé (Togo)

References

Kouassi E., et al. “Système immunitaire”. Environnement Et Santé Publique (2003): 687-698.
Cooper GS., et al. “Rescent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases”. Journal of Autoimmunity 33 (2009): 197-207.
Ka M M., et al. “La problématique des Maladies Auto-immunes en Afrique”. RAFMI 1-1 (2017): 7-8.
Kane BS., et al. “Maladies systémiques en médecine interne “contexte africain”: aspects épidémiologiques et classification”. La Revue de Médecine Interne 1 (2016): 37.
Mijiyawa M., et al. “Les connectivites en consultation hospitalière à Lomé (Togo)”. La Revue de Médecine Interne 1 (1999): 13-17.
Ouédraogo DD., et al. “Les connectivites en pratique hospitalière à Ouagadougou”. Médecine et Santé Tropicales3 (2014): 271-274.
Dioussé P., et al. “Profil épidémio-clinique des maladies auto-immunes systémiques dans un service de Dermatologie”. RAFMI2 (2017): 18-21.
Wemeau JL and Proust-Lemoine E. “Polyendocrinopathies auto-immunes de type 1: Caractéristiques cliniques et évolutives sur la base d’une enquête inter-régionale et nationale”. Bulletin de L'Académie Nationale de Médecine 1 (2013): 19-30.
Humbel RL. “Maladies auto-immunes des glandes endocrines”. GEAI L’info 5 (2002): 1-23.
Fagbemi KA., et al. “Aspects épidémiologiques du diabète de type 1 à la banque d’insuline de Cotonou (Bénin)”. International Journal of Biological and Chemical Sciences 3 (2017): 1085-1095.
Timóteo C., et al. “Growth and puberty in type 1 diabetes mellitus - experience from a pediatric endocrinology unit”. Acta Medica Portuguesa4 (2012): 213-218.
Jarosz-Chobot P., et al. “Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025”. Diabetologia3 (2011): 508-515.
Mbadinga H., et al. “Nsakala-kibangou N.: hyperthyroïdies : aspects étiologiques et cliniques étude de 72 cas au chu de Brazzaville (Congo)”. Médecine d'Afrique Noire 44 (1997): 342-344
Balaka A., et al. “La maladie de Basedow : aspects épidémiologiques, diagnostiques et évolutifs au CHU Sylvanus Olympio de Lomé”. Rev Afr End Métab Nut2 (2016): 6-9.
Bilosi M., et al. “La thyroïdectomie subtotale bilatérale de réduction reste-t-elle indiquée dans la maladie de Basedow?” Annales de Chirurgie2 (2002): 115-120.
Wemeau JL. “Hyperthyroïdie: étiologie, physiopatologie, diagnostic, évolution, traitement”. La Revue du Praticien 12 (1998): 1377-1384.
Lokrou A., et al. “Aspects cliniques, hormonaux et thérapeutiques de la maladie de Basedow à Abidjan: étude préliminaire à partir de 6 cas”. Médecine d'Afrique Noire 7 (1988): 555-558.
Zulfiqar AA., et al. “Anémie hémolytique auto-immune: Expérience de deux services de médecine interne”. La Revue de Médecine Interne1 (2016): A131-A132.
Hadj Kacem F., et al. “Démarche diagnostique et thérapeutique d’une hypothyroïdie primaire”. I. M. Sfax 29 (2018): 9-17.
Kane BS., et al. “Maladies systémiques en médecine interne “contexte africain”: aspects épidémiologiques et classification”. La Revue de Médecine Interne 37 (2016): A37.
Kakpovi K., et al. “Profil de la polyarthrite rhumatoïde en consultation rhumatologique à Lomé (Togo)”. European Scientific Journal15 (2017): 125-132.
Malemba JJ., et al. “The epidemiology of rheumatoid arthritis in Kinshasa, Democratic Republic of Congo. A population-based study”. Rheumatology 51 (2012): 1644-1647.
Atouf O., et al. “Polymorphisme HLA et polyarthrite rhumatoïde précoce dans la population marocaine”. Revue du Rhumatisme 75 (2008): 824-830.
Kombate K., et al. “Le lupus systémique à Lomé, Togo”. Tropical Medicine and Health 68 (2008): 283-286.
Diop M M., et al. “Les modes de révélation du lupus érythémateux systémique à Dakar (Sénégal) : à propos d’une série de 161 cas”. RAFMI 1.44 (2014): 12-15.
Lopez P., et al. “Epidemiology of systemic lupus erythematosus in northern Spanish population : Gender and age affluence on immunological features”. Lupus11 (2003): 860-865.
Missounga L., et al. “La connectivite mixte: prévalence et caractéristiques cliniques chez le noir africain, étude de 7 cas au Gabon et revue de la littérature”. The Pan African Medical Journal 27 (2017): 162.
Houzou P., et al. “Rheumatic diseases profile of 13577 West African patients”. Journal Medical Tunisie 01 (2013): 16-20.
Ouedraogo DD., et al. “Les connectivites en pratique hospitalière à Ouagadougou (Burkina Faso)”. Médecine et Santé Tropicales 3 (2014): 2714.

Citation

Citation: Komi Dzidzonu Nemi., et al. “Epidemiological Profile and Classification of Autoimmune Diseases in an Internal Medicine Service in Lomé (Togo)". Acta Scientific Medical Sciences 4.5 (2020): 71-74.

Copyright

Copyright: © 2020 Komi Dzidzonu Nemi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.